Residency · Residency · Preventive Medicine

Surveillance Systems and Disease Reporting

Overview

Public health surveillance is the ongoing, systematic collection, analysis, interpretation, and dissemination of health data. Often described as "information for action," surveillance forms the foundation of public health practice. Legal mandates for disease reporting provide the backbone of communicable disease control, while modern surveillance systems integrate traditional notifiable disease reporting with syndromic, sentinel, and digital approaches.

Types of Surveillance

Passive Surveillance

In passive surveillance, healthcare providers and laboratories report cases to public health authorities as they are identified. The system relies on clinicians to recognize reportable conditions and comply with reporting requirements. While inexpensive to maintain, passive surveillance consistently underestimates the true disease burden because underreporting is the norm rather than the exception. The National Notifiable Diseases Surveillance System (NNDSS) is the primary example. Estimated completeness varies widely, ranging from 10% to 90% depending on the disease.

Active Surveillance

Active surveillance involves health authorities proactively seeking out cases through regular contact with healthcare facilities, laboratories, or communities. This approach achieves more complete case ascertainment but is substantially more resource-intensive. It is typically reserved for high-priority diseases or deployed during outbreaks. The Active Bacterial Core surveillance (ABCs) system for invasive bacterial diseases exemplifies this approach. Polio eradication efforts worldwide rely on active surveillance for acute flaccid paralysis.

Sentinel Surveillance

Sentinel surveillance uses selected reporting sites — called sentinel sites — to provide high-quality data on specific conditions. While not population-based, it yields detailed clinical and epidemiologic information that would be impractical to collect universally. ILINet (the Influenza-Like Illness Surveillance Network) consists of outpatient sentinel practices reporting the proportion of visits for influenza-like illness, providing crucial data for tracking seasonal influenza activity.

Syndromic Surveillance

Syndromic surveillance monitors pre-diagnostic health indicators such as emergency department chief complaints, pharmacy sales, and school absenteeism. It is designed for early detection of outbreaks or bioterrorism events, offering near real-time data collection and analysis. The tradeoff is high sensitivity but low specificity, meaning the system generates many false alarms. The BioSense Platform and ESSENCE (Electronic Surveillance System for the Early Notification of Community-based Epidemics) are major examples.

Laboratory-Based Surveillance

Laboratory-based surveillance relies on laboratory confirmation of diagnoses, providing pathogen-specific data including antimicrobial susceptibility patterns and molecular typing information. Technologies such as pulsed-field gel electrophoresis (PFGE) and whole genome sequencing (WGS) enable detection of outbreaks that might otherwise go unrecognized. PulseNet, the national molecular subtyping network for foodborne illness surveillance, exemplifies how molecular laboratory data can link geographically dispersed cases to a common source.

Vital Statistics Surveillance

Vital statistics surveillance encompasses the registration of births and deaths. Death certificate data provide mortality trends and cause-specific death rates, while birth certificate data supply maternal and infant health indicators. The National Vital Statistics System (NVSS), managed by the National Center for Health Statistics (NCHS), is the primary system.

Legal Framework for Disease Reporting

Mandatory Reporting

Disease reporting authority resides at the state level, with each state defining its own list of reportable conditions. The Council of State and Territorial Epidemiologists (CSTE) and CDC maintain a nationally notifiable conditions list, though this is recommended rather than legally mandated at the federal level. Healthcare providers, laboratories, and hospitals all carry legal obligations to report. Reporting timeframes vary by urgency: some conditions (such as botulism, plague, and anthrax) require immediate notification, others must be reported within 24 hours, and still others within one week. Importantly, HIPAA permits disclosure of protected health information to public health authorities for disease reporting without patient consent.

Key Reportable Conditions

Conditions requiring immediate notification include anthrax, botulism, plague, viral hemorrhagic fevers, and smallpox. Those requiring reporting within 24 hours include measles, meningococcal disease, cholera, and rabies. Conditions reportable within one week include hepatitis A, B, and C, HIV, tuberculosis, sexually transmitted infections (gonorrhea, chlamydia, syphilis), and Lyme disease. Individual states may add conditions beyond the national list based on local epidemiologic priorities.

International Health Regulations (IHR 2005)

Under the International Health Regulations of 2005, WHO member states are required to report events that may constitute a Public Health Emergency of International Concern (PHEIC). The IHR establishes core capacity requirements for detection, reporting, and response. A decision instrument helps national authorities determine whether a given event meets the threshold for reporting to WHO.

Evaluation of Surveillance Systems

CDC Framework for Evaluating Public Health Surveillance Systems

The CDC framework identifies nine key attributes for evaluation. Simplicity refers to ease of operation and data flow. Flexibility is the ability to adapt to changing conditions or newly emerging diseases. Data quality encompasses completeness and validity. Acceptability reflects willingness of participants to contribute data. Sensitivity refers to both the proportion of true cases detected and the ability to detect outbreaks. Predictive value positive is the proportion of reported cases that are actually true cases. Representativeness indicates whether captured cases reflect the true distribution by person, place, and time. Timeliness measures the speed of data flow from case occurrence to availability for action. Stability reflects the system's reliability and consistent availability.

Common Challenges

Surveillance systems routinely face underreporting and incomplete data, reporting delays, inconsistent case definitions across jurisdictions, data silos and lack of interoperability between systems, resource constraints at local and state health departments, and difficulty maintaining adequate workforce capacity for surveillance activities.

Modern and Digital Surveillance

Electronic Laboratory Reporting (ELR)

Electronic laboratory reporting enables automated transmission of reportable laboratory results to public health agencies, reducing the reporting burden on providers while improving timeliness and completeness. The Promoting Interoperability program (formerly Meaningful Use) provides financial incentives for ELR adoption by healthcare systems.

Genomic Surveillance

Whole genome sequencing of pathogens has transformed outbreak detection and tracking. SARS-CoV-2 variants were tracked through genomic surveillance platforms including GISAID and the CDC genomic surveillance system. This technology enables identification of transmission chains and detection of antimicrobial resistance genes. PulseNet has transitioned from PFGE to WGS for foodborne pathogen tracking, substantially improving discriminatory power.

Digital Epidemiology

Internet-based surveillance approaches include Google Trends analysis, social media monitoring, and platforms like HealthMap. Participatory surveillance tools such as Outbreaks Near Me (formerly Flu Near You) allow the public to report symptoms directly. Limitations include the digital divide affecting representativeness, data noise, privacy concerns, and the lack of clinical confirmation. These tools complement but cannot replace traditional surveillance systems.

Wastewater Surveillance

Wastewater surveillance monitors sewage for pathogen biomarkers such as SARS-CoV-2 RNA or poliovirus genetic material. It provides population-level monitoring independent of individual healthcare-seeking behavior, making it useful for early detection of outbreaks and tracking trends in communities where many infections go undiagnosed. The National Wastewater Surveillance System (NWSS) was established during the COVID-19 pandemic and is being expanded to cover additional pathogens.

<image>A diagram showing the flow of disease surveillance data from initial case detection to public health action. The flow starts with a patient presenting to a healthcare provider, then moves through laboratory testing, case reporting (showing both passive and active pathways), data collection at local health department, aggregation at state health department, reporting to CDC/NNDSS, and finally data analysis leading to public health action. Arrows show feedback loops where surveillance findings inform intervention and policy. Timeframes for reporting are annotated at each step. Professional public health infographic style.</image>

<image>A comparison matrix of surveillance system types. Rows represent system types (passive, active, sentinel, syndromic, laboratory-based, vital statistics). Columns represent key attributes: cost, completeness of case ascertainment, timeliness, data quality, and primary use case. Each cell contains a rating (low/medium/high) with a color-coded indicator. The matrix includes a representative example system for each type. Clean, organized table format suitable for medical education.</image>

<image>An infographic showing the CDC framework attributes for evaluating surveillance systems. Nine attributes (simplicity, flexibility, data quality, acceptability, sensitivity, predictive value positive, representativeness, timeliness, stability) are arranged in a circular or spoke-wheel layout around a central "Surveillance System Evaluation" hub. Each attribute has a brief definition and a small icon representing its concept. The diagram indicates that no single attribute is most important -- the optimal balance depends on the surveillance purpose. Professional public health education style.</image>

Clinical Pearls

Surveillance is "information for action" — data that are collected but never analyzed or acted upon serve no public health purpose. Passive surveillance always underestimates the true disease burden, and interpretations should be adjusted accordingly. Disease reporting is a legal obligation for clinicians, and knowing your state's reportable conditions list is a professional responsibility. HIPAA does not prevent reporting of notifiable diseases to public health authorities — this is a common misconception. Syndromic surveillance is designed for early outbreak detection rather than case confirmation, so false alarms should be expected. Genomic surveillance has transformed outbreak investigation, with PulseNet's WGS capabilities enabling identification of multistate foodborne outbreaks originating from a single contaminated source. Wastewater surveillance emerged as a major public health tool during COVID-19 and is being expanded to monitor other pathogens. For board preparation, understand the distinction between sensitivity of a surveillance system (the proportion of true cases detected in a population) and sensitivity of a diagnostic test (the proportion of diseased individuals who test positive).

References

• CDC. Updated Guidelines for Evaluating Public Health Surveillance Systems. MMWR. 2001;50(RR-13):1-35.
• Thacker SB, Berkelman RL. Public health surveillance in the United States. Epidemiol Rev. 1988;10:164-190.
• International Health Regulations (2005). 3rd ed. WHO; 2016.
• CDC. National Notifiable Diseases Surveillance System (NNDSS). https://www.cdc.gov/nndss/
• Brownstein JS, Freifeld CC, Madoff LC. Digital disease detection. N Engl J Med. 2009;360:2153-2157.
• Kirby AE, et al. Using wastewater surveillance data to support the COVID-19 response. MMWR. 2021;70(36):1242-1244.

Read this lecture as Markdown